Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Upadacitinib improved multiple immune-related conditions in one patient.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib might be used to treat hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Interferon and ribavirin can cause serious skin reactions and other health issues.

M50054 may help treat hepatitis and hair loss from chemotherapy.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.